Carcinoembryonic Antigen (CEA) Market Is Projected To Be Around $2.51 Billion By 2022
October 25, 2017 08:54 ET
|
Crystal Market Research
LAS VEGAS, Oct. 25, 2017 (GLOBE NEWSWIRE) -- The Carcinoembryonic Antigen (CEA) Market was worth USD 1.36 billion in the year of 2012 and is expected to reach approximately USD 2.51 billion by 2022,...